Claudia Agabiti-Rosei1,2, Anna Paini3, Carolina De Ciuceis3, Sarah Withers4, Adam Greenstein4, Anthony M Heagerty4, Damiano Rizzoni3. 1. Department of Medicine, Manchester University, Manchester, UK. agabiticlaudia@gmail.com. 2. Clinica Medica, Department of Medical and Surgical Sciences, University of Brescia, c/o 2a Medicina Spedali Civili di Brescia, Piazza Spedali Civili 1, 25100, Brescia, Italy. agabiticlaudia@gmail.com. 3. Clinica Medica, Department of Medical and Surgical Sciences, University of Brescia, c/o 2a Medicina Spedali Civili di Brescia, Piazza Spedali Civili 1, 25100, Brescia, Italy. 4. Department of Medicine, Manchester University, Manchester, UK.
Abstract
PURPOSE OF REVIEW: In this review, we discuss the role of perivascular adipose tissue (PVAT) in the modulation of vascular contractility and arterial pressure, focusing on the role of the renin-angiotensin-aldosterone system and oxidative stress/inflammation. RECENT FINDINGS: PVAT possesses a relevant endocrine-paracrine activity, which may be altered in several pathophysiological and clinical conditions. During the last two decades, it has been shown that PVAT may modulate vascular reactivity. It has also been previously demonstrated that inflammation in adipose tissue may be implicated in vascular dysfunction. In particular, adipocytes secrete a number of adipokines with various functions, as well as several vasoactive factors, together with components of the renin-angiotensin system which may act at local or at systemic level. It has been shown that the anti-contractile effect of PVAT is lost in obesity, probably as a consequence of the development of adipocyte hypertrophy, inflammation, and oxidative stress. Adipose tissue dysfunction is interrelated with inflammation and oxidative stress, thus contributing to endothelial dysfunction observed in several pathological and clinical conditions such as obesity and hypertension. Decreased local adiponectin level, macrophage recruitment and infiltration, and activation of renin-angiotensin-aldosterone system could play an important role in this regard.
PURPOSE OF REVIEW: In this review, we discuss the role of perivascular adipose tissue (PVAT) in the modulation of vascular contractility and arterial pressure, focusing on the role of the renin-angiotensin-aldosterone system and oxidative stress/inflammation. RECENT FINDINGS: PVAT possesses a relevant endocrine-paracrine activity, which may be altered in several pathophysiological and clinical conditions. During the last two decades, it has been shown that PVAT may modulate vascular reactivity. It has also been previously demonstrated that inflammation in adipose tissue may be implicated in vascular dysfunction. In particular, adipocytes secrete a number of adipokines with various functions, as well as several vasoactive factors, together with components of the renin-angiotensin system which may act at local or at systemic level. It has been shown that the anti-contractile effect of PVAT is lost in obesity, probably as a consequence of the development of adipocyte hypertrophy, inflammation, and oxidative stress. Adipose tissue dysfunction is interrelated with inflammation and oxidative stress, thus contributing to endothelial dysfunction observed in several pathological and clinical conditions such as obesity and hypertension. Decreased local adiponectin level, macrophage recruitment and infiltration, and activation of renin-angiotensin-aldosterone system could play an important role in this regard.
Entities:
Keywords:
Hypoxia; Melatonin; Oxidative stress; Perivascular adipose tissue; Small arteries
Authors: Claudia Agabiti-Rosei; Carolina De Ciuceis; Claudia Rossini; Enzo Porteri; Luigi F Rodella; Sarah B Withers; Anthony M Heagerty; Gaia Favero; Enrico Agabiti-Rosei; Damiano Rizzoni; Rita Rezzani Journal: J Hypertens Date: 2014-06 Impact factor: 4.844
Authors: Beatriz Gálvez; Javier de Castro; Diana Herold; Galyna Dubrovska; Silvia Arribas; M Carmen González; Isabel Aranguez; Friedrich C Luft; M Pilar Ramos; Maik Gollasch; Maria S Fernández Alfonso Journal: Arterioscler Thromb Vasc Biol Date: 2006-04-06 Impact factor: 8.311
Authors: Renate Schnabel; Martin G Larson; Josée Dupuis; Kathryn L Lunetta; Izabella Lipinska; James B Meigs; Xiaoyan Yin; Jian Rong; Joseph A Vita; Christopher Newton-Cheh; Daniel Levy; John F Keaney; Ramachandran S Vasan; Gary F Mitchell; Emelia J Benjamin Journal: Hypertension Date: 2008-04-21 Impact factor: 10.190
Authors: Sarah R Anthony; Adrienne R Guarnieri; Anamarie Gozdiff; Robert N Helsley; Albert Phillip Owens; Michael Tranter Journal: Clin Sci (Lond) Date: 2019-11-29 Impact factor: 6.124
Authors: Taylor R Miron; Emma D Flood; Nathan R Tykocki; Janice M Thompson; Stephanie W Watts Journal: Pharmacol Res Date: 2021-11-21 Impact factor: 10.334
Authors: Elizabeth A Jacobsen; David J Jackson; Enrico Heffler; Sameer K Mathur; Albert J Bredenoord; Ian D Pavord; Praveen Akuthota; Florence Roufosse; Marc E Rothenberg Journal: Annu Rev Immunol Date: 2021-03-01 Impact factor: 28.527
Authors: Stephanie W Watts; Emma S Darios; G Andres Contreras; Hannah Garver; Gregory D Fink Journal: Am J Physiol Heart Circ Physiol Date: 2021-04-30 Impact factor: 5.125